Home > News > Study Using Nanogen Assay
June 8th, 2005
Study Using Nanogen Assay
Abstract:
Nanogen, Inc. today announced that a study published in the European Journal of Heart Failure concluded that for patients with severe congestive heart failure, a significantly higher risk of one-year mortality was associated with elevated levels of N-terminal brain natriuretic peptide (NT-proBNP).
Source:
prnewswire
| Related News Press |
Announcements
Decoding hydrogen‑bond network of electrolyte for cryogenic durable aqueous zinc‑ion batteries January 30th, 2026
COF scaffold membrane with gate‑lane nanostructure for efficient Li+/Mg2+ separation January 30th, 2026
Tools
Metasurfaces smooth light to boost magnetic sensing precision January 30th, 2026
From sensors to smart systems: the rise of AI-driven photonic noses January 30th, 2026
Japan launches fully domestically produced quantum computer: Expo visitors to experience quantum computing firsthand August 8th, 2025
|
|
||
|
|
||
| The latest news from around the world, FREE | ||
|
|
||
|
|
||
| Premium Products | ||
|
|
||
|
Only the news you want to read!
Learn More |
||
|
|
||
|
Full-service, expert consulting
Learn More |
||
|
|
||